SPAG4 and glioblastoma: SPAG4 promotes survival of cancer cells under hypoxic conditions and leads to poor prognosis of several cancers, including renal cell carcinoma (45), glioblastoma (46), Pancreatic Ductal Adenocarcinoma (47).